Search

Your search keyword '"Bhateja, P."' showing total 28 results

Search Constraints

Start Over You searched for: "Bhateja, P." Remove constraint "Bhateja, P." Database Unpaywall Remove constraint Database: Unpaywall
28 results on '"Bhateja, P."'

Search Results

1. Scalp Irradiation with 3D-Milled Bolus: Dosimetric, Toxicity, and Oncologic Outcomes

2. Weekly Paclitaxel, Carboplatin, and Cetuximab (PCC) as Treatment for Recurrent or Metastatic Head and Neck Squamous-cell Carcinoma (RM-HNSCC) that Progressed on Immune Checkpoint Inhibitors (ICI): A Retrospective Analysis

5. Comparative Analysis of Tumor Microbiome, Molecular Profile and Immune Cell Abundance by HPV Status in Head and Neck Cancers and Their Impact on Survival

6. Association of Tumor Microbiome and Hypoxia Expression Signatures in Different Anatomic Subsites of Head and Neck Cancer

7. Impact of Tobacco, Marijuana and Alcohol Use on Overall Survival in Recurrent Metastatic Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors

8. Defining the Psychiatric and Financial Landscape of Mental and Substance Use Disorders in Head and Neck Cancer Patients

9. Brachial Plexus Tolerance to High-Dose Radiation in the Re-Irradiation Setting

10. 888P Clinical predictors for survival with the addition of chemotherapy in patients with recurrent-metastatic squamous cell carcinoma of the head and neck after progression on immune checkpoint inhibitors

11. A predictive survival model for patients with head and neck squamous cell carcinoma treated with immune check point inhibitors

12. 948P Pre-treatment characteristics and long-term outcomes of recurrent-metastatic head and neck cancer patients treated with immune checkpoint inhibitors

14. Body-Mass Index (BMI) and early stage as predictors of papillomavirus infection in H&N cancers

15. Treatment outcomes of head and neck cancer patients 70 years and older receiving different chemo-radiation combinations

16. A nomogram based prognostic score to predict overall survival (OS) in recurrent-metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with immune checkpoint inhibitors (ICI)

19. Clinical Predictors of Locoregional Failure in Advanced Laryngeal Cancer Treated With Definitive Chemotherapy and Radiation

22. Nasogastric Enteral Feeding Is Superior to Percutaneous Gastrostomy in Preventing Late Pharyngeal Dysfunction in Long-Term Survivors of Locoregionally Advanced Head and Neck Squamous Cell Cancer (HNSCC) Treated With Definitive Chemoradiation Therapy (CRT)

23. Reduction of Severe Late Toxicity After Definitive Chemoradiation Therapy (CRT) Using Intensity Modulated Radiation Therapy (IMRT) in Non-HPV–Associated Head and Neck Squamous Cell Carcinoma (HNSCC): More than Xerostomia

Catalog

Books, media, physical & digital resources